Department of Medicine faculty have received notice of the following research, clinical trials, CME or other training awards.
[tabs style="vertical"][tab title="Sponsored research"]James M. Brennan of Cardiology has received an award (1U01-FD004591-01) from the Food and Drug Administration for a project entitled "Efficiencies for Outcome Ascertainment throughout the Total Product Life Cycle." Total funding will be $724,826.
James P. Daubert of Cardiology has received a sub-award (U01-HL096607-) through the University of Rochester for a project entitled "Ranolazine in High-Risk ICD Patients (RAID)." Total funding will be $18,642.
Eric L. Eisenstein of Cardiology has received a sub-award (1UH2-AT007784-01) through the University of Iowa for a project entitled "Nighttime Dosing of Anti-Hypertensive Medications: A Pragmatic Clinical Trial." Total funding will be $125,600.
Raymond J. Kim of Cardiology has received a sub-award (LSDF 3983577) through the University of Washington for a project entitled "Gd-Nanoparticles for a Safer and More Effective MRI." Total funding will be $19,939.
Eugene Z. Oddone of General Internal Medicine has received an award (HHSN275201100476P) from the National Institutes of Health for a project entitled "Develop Training in the principles, methods, and ethics of clinical research under the Clinical Research Reproductive Scientist Training (CREST)." Total funding will be $24,999.
Michael A. Hauser of Medical Genetics has received an award (1P50-DK096415-01) from the National Institutes of Health for a project entitled "Biobanking Core." Total funding will be $406,774.
Jeffrey Crawford of Medical Oncology has received a sub-award (1R01-CA157409-01A1) through the University of Virginia - Charlottesville for a project entitled "A Decision Aid with HRQL Assessment to Reduce Costs in the Treatment of NSCLC." Total funding will be $120,946.
Victoria L. Seewaldt of Medical Oncology has received an award from the University of California - Berkeley for a project entitled "Minority Supplement for Dana Baker." Total funding will be $158,526.
Thomas M. Coffman of Nephrology has received an award from the Edna and Fred L. Mandel, Jr. Foundation for a project entitled "Coffman Lab", a part of Victor J. Dzau's project entitled "Mandel Foundation Composite Program Project Grant."
Daniel Laskowitz of Neurology has received a sub-award (UCB) through the University of North Carolina for a project entitled "Neurology Clinical Drug Development Fellowship." Total funding will be $120,247.[/tab][tab title="Industry-sponsored clinical trials"]William E. Kraus of Cardiology has received a sub-award (HHSN271201200002I) through KAI Research, Inc. for a project entitled "KAI Subcontract: CALERIE Public Dataset Ancillary Study." Total funding will be $27,827.
Kenneth W. Mahaffey of Cardiology has received an award from Amgen, Inc. for a project entitled "Amgen Study 20120102 CEC." Total funding will be $211,361.
Kenneth W. Mahaffey of Cardiology has received an award from GlaxoSmithKline for a project entitled "Clinical Events Committee & Data Monitoring Committee for GSK Mepolizumab Program of Studies." Total funding will be $1,143,373.
Andrew J. Muir of Gastroenterology has received an award from Gilead Sciences, Inc. for a project entitled "Liver Fibrosis Program GS-US-321-0106." Total funding will be $963,094.
Melissa D. Johnson of Infectious Diseases has received an award from Astellas Pharma Global Development, Inc for a project entitled "Astellas WSA-CS-003." Total funding will be $69,884.
Cameron R. Wolfe of Infectious Diseases has received an award from GlaxoSmithKline for a project entitled "GSK Contract C-218150." Total funding will be $50,000.
Kimberly L. Blackwell of Medical Oncology has received an award from Novartis Pharmaceuticals Corporation for a project entitled "A multicenter, open-label, dose escalation, Phase I study of LJM716 administered intravenously in combination with trastuzumab in patients with HER2 overexpressing metastatic breast cancer." Total funding will be $230,049.
Shiaowen D. Hsu of Medical Oncology has received an award from AbbVie Inc. for a project entitled "Evaluation of c-Met in Colorectal Cancer Xenografts." Total funding will be $280,245.
Annick Desjardins of Neurology has received an award from Genentech, Inc. for a project entitled "Phase II Trial of Bevacizumab, Radiation Therapy and Temodar with continuation of Bevacizumab." Total funding will be $734,866.
Shelby Reed of Other Medicine has received an award from Iris Molecular Diagnostics, Inc for a project entitled "Modeling the Cost-Effectiveness of the NADiA ProsVue PDA Slope as an Independent Prognostic Marker for Identifying Men at Reduced Risk for Clinical Recurrence of Prostate Cancer after Radical Prostatectomy." Total funding will be $180,844. [/tab]
[/tabs]